Clinical trials
Phase 2 Lymphoma trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 3 |
| Celgene | 2 |
| Aalborg University Hospital | 1 |
| Hoffmann-La Roche | 1 |
| Lars Møller Pedersen | 1 |
| Rigshospitalet, Denmark | 1 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 10 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Hypogonadism | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.